Obesity represents a critical public health concern, often linked to low-grade chronic inflammation starting in childhood. This study aimed to evaluate the impact of a 12-week kinesiotherapy program on physical performance and levels of leptin and C-reactive protein (CRP) in overweight and obese children. Methods: Conducted at the Filantropia Municipal Clinical Hospital, 160 children aged 6 to 15 were randomly assigned to a study group (SG, n = 80) and a control group (CG, n = 80). The SG engaged in a tailored kinesiotherapy program, while the CG maintained their usual activities. All children and their families learned five key principles for preventing and managing obesity. Results: Results indicated significant improvements in the SG, with enhancements in the 6 min walking distance, Timed Up and Go test, and walking cadence (all p-values < 0.001). Notably, leptin and CRP levels (23.02 ± 7.17 to 16.62 ± 7.83, 4.13 ± 1.00 to 3.90 ± 0.95 mg/l, respectively) decreased significantly in the SG, contrasting with no significant changes in the CG. Regression analysis revealed a positive correlation between leptin levels and physical activity in the SG (coefficient: 0.5642, R-squared: 0.266). Conclusions: These findings suggest that targeted exercise programs can effectively enhance physical performance and reduce inflammation markers in overweight children, highlighting the importance of tailored interventions in managing obesity.

Background/Objectives: Childhood obesity is a critical public health issue associated with biomechanical and functional impairments that influence gait and physical performance. This study aimed to evaluate the impact of a six-month personalized kinetic program on gait parameters and pelvic kinematics in overweight and obese children. Methods: The prospective observational study included 100 children aged 8 to 15, divided into a study group (SG, n = 50) and a control group (CG, n = 50). The SG participated in a tailored kinetic program focusing on flexibility, strength, and coordination exercises, while the CG maintained their usual activities. The program consisted of 60 min sessions conducted three times per week over a six-month period. Gait parameters and pelvic symmetry indices were assessed using the BTS G-WALK system. Ethical approval was granted by the Ethics Committee of the University of Medicine and Pharmacy, Craiova, under approval no. 38/1 March 2022. Results: Significant improvements were observed in the SG, with increases in cadence (steps/min), walking speed (m/s), and pelvic symmetry indices across all planes (sagittal, frontal, and transverse) (p < 0.0001). In contrast, no significant changes were observed in pelvic symmetry indices in the CG (p > 0.01). The Spearman correlation matrix and heatmaps highlighted a strong correlation between improved gait parameters and participation in the kinetic program (correlation coefficient over 0.45). Conclusions: The findings demonstrate that a targeted kinetic program can significantly improve gait mechanics and pelvic kinematics in overweight and obese children. These results emphasize the importance of personalized exercise interventions in managing obesity-related gait abnormalities and improving functional mobility.

Background and Objectives. Bilateral knee osteoarthritis (KOA) in older patients compromises mobility and quality of life. Gait analysis provides objective, reproducible measures of physical performance. This study evaluated the integration of gait analysis for longitudinal monitoring and personalized rehabilitation, while ultrasound was performed only at baseline for characterization and did not inform adjustments to the interventions. Materials and Methods. We conducted a 6-week, randomized, parallel-group clinical trial including 130 participants aged ≥65 years. Patients were randomized to a Study Group (SG, n = 64) receiving 10 sessions of a comprehensive rehabilitation program (conventional measures plus gait training) or a Control Group (CG, n = 66) receiving 10 sessions of conventional rehabilitation (electrotherapy with magnetodiaflux, TENS, therapeutic ultrasound, low-intensity laser, plus standard kinesitherapy). Interventions were delivered daily, 5 days/week, over 2 consecutive weeks. Gait outcomes (BTS G-WALK/G-SENSOR 2) included TUG, Symmetry Index, 6MWD, and cadence; functional outcomes included VAS pain, WOMAC, and Lequesne Index. Quadriceps morphology was assessed sonographically, and a height-normalized quadriceps thickness index (QHNI) was calculated. Results. Of 130 randomized, 112 completed (93.3%). Compared with control, the intervention produced significant, clinically meaningful improvements: 6MWD increased by approximately 59 m, cadence by ~9 steps/min; TUG improved by ~2.6 s; gait symmetry by ~4–5 points; VAS pain decreased by ~1.7 points; WOMAC total by ~8.5 points; and Lequesne Index by ~2 points (all p < 0.001). QHNI showed no significant association with anthropometrics and performance measures, indicating limited value as a linear predictor at baseline; nonlinear models or subgroup analyses may be warranted. Conclusions. Both neuromuscular-focused rehabilitation and the conventional program improved gait and clinical outcomes. Integrating gait analysis with ultrasound evaluation enables comprehensive monitoring and supports personalized interventions to reduce joint loading and optimize gait mechanics in older patients with bilateral KOA.

Our purpose is to emphasize the role of botulinum toxin in spasticity therapy and functional recovery in patients following strokes. Our retrospective study compared two groups, namely ischemic and hemorrhagic stroke patients. The study group (BT group) comprised 80 patients who received focal botulinum toxin as therapy for an upper limb with spastic muscle three times every three months. The control group (ES group) comprised 80 patients who received only medical rehabilitation consisting of electrostimulation and radial shockwave therapy for the upper limb, which was applied three times every three months. Both groups received the same stretching program for spastic muscles as a home training program. We evaluated the evolution of the patients using muscle strength, Ashworth, Tardieu, Frenchay, and Barthel scales. The analysis indicated a statistically significant difference between the two groups for all scales, with better results for the BT group (p < 0.0001 for all scales). In our study, the age at disease onset was an important prediction factor for better recovery in both groups but not in all scales. Better recovery was obtained for younger patients (in the BT group, MRC scale: rho = −0.609, p-value < 0.0001; Tardieu scale: rho = −0.365, p-value = 0.001; in the ES group, MRC scale: rho = −0.445, p-value < 0.0001; Barthel scale: rho = −0.239, p-value = 0.033). Our results demonstrated the effectiveness of botulinum toxin therapy compared with the rehabilitation method, showing a reduction of the recovery time of the upper limb, as well as an improvement of functionality and a reduction of disability. Although all patients followed a specific kinetic program, important improvements were evident in the botulinum toxin group.

Background: Sarcopenic obesity, characterized by reduced skeletal muscle mass and excess adiposity, is strongly associated with chronic pain and functional decline in older adults. Objective: This prospective controlled trial without randomization investigated the effects of a structured, three-phase rehabilitation program on physical performance, pain, and sarcopenia-specific quality of life in elderly patients with sarcopenic obesity and chronic pain. Methods: In this study, 82 participants were enrolled and allocated to a study group (SG, n = 40), receiving supervised rehabilitation, nutritional counseling, and supplementation, or to a control group (CG, n = 42), which did not receive rehabilitation. The final analysis included 35 patients in SG and 36 in CG. Outcomes were assessed at baseline and six months using the Sarcopenia Quality of Life Questionnaire (SarQoL), Short Physical Performance Battery (SPPB), Numeric Rating Scale (NRS), and Pressure Pain Threshold (PPT). Results: The SG showed significant improvements in all outcomes: SarQoL increased from 57.02 to 63.98, SPPB increased from 7.14 to 8.4, PPT increased from 69.31 to 78.05, and NRS decreased from 6.94 to 4.65 (all p < 0.001). The CG showed no significant changes. Conclusions: The implementation of a structured, three-phase rehabilitation program resulted in clinically and statistically significant improvements in physical performance, pain perception, and sarcopenia-related quality of life in older adults with sarcopenic obesity and chronic pain.

Chronic cervical radiculopathy (CR) is a common cause of pain and disability in adults. The primary objective of our study was to evaluate the efficacy of a structured, multimodal rehabilitation program, with or without adjunct neurotrophic supplementation, in chronic cervical radiculopathy; secondarily, this study investigates which patients are most likely to benefit from neurotrophic supplementation and aims to assess effects on pain, cervical mobility, disability, and daily activities to guide individualized care. Patients and Methods: In this prospective, randomized controlled trial, 82 patients with chronic CR were allocated to a study group (SG, n = 42) receiving a three-month multimodal rehabilitation program plus daily neurotrophic supplementation (named PHSD) or a control group (CG, n = 40) receiving the same rehabilitation alone. Outcome measures included the Visual Analogue Scale (VAS), Neck Disability Index (NDI), cervical mobility indexes (CSI—Chin-Sternum Index; OWI—Occiput-Wall Index; TAI—Tragus-Acromion Index), and Katz ADL (Activity of Daily Living) Index, assessed at baseline and after three months. Results: Both groups showed significant improvements, but the SG demonstrated greater reductions in pain (median VAS change: 8.16 ± 0.72 vs. 5.11 ± 0.70, p < 0.001) and disability (mean NDI change: 24.71 ± 5.13 vs. 20.90 ± 4.49, p < 0.001). Cervical mobility indexes improved in both groups, with larger gains in the SG (p < 0.01), supporting the potential benefits of adding neurotrophic supplementation. Conclusions: A structured multimodal rehabilitation program significantly improves pain, mobility, and disability in chronic CR, while combining it with PHSD may enhance these effects. Further randomized trials are needed to confirm these findings and establish standardized conservative treatment protocols.